17. A wholesale distributor shall exercise due diligence in accordance with the following requirements, unless the commissioner waives any requirement. Prior to the first purchase of prescription drugs for distribution in this State from another wholesale distributor that is not licensed in this State pursuant to this act, the purchasing wholesale distributor shall obtain the following information from the selling wholesale distributor:

a. verification of the wholesale distributor’s status as an authorized distributor of record, if applicable, for which purpose inclusion of the wholesale distributor’s business name on the manufacturer’s list of authorized distributors of record, as required in section 8 of this act, shall be deemed acceptable for verification purposes;

b. a list of the state in which the wholesale distributor is domiciled and the states into which it ships prescription drugs;

c. the wholesale distributor’s most recent facility inspection reports;

d. copies of relevant general and product liability insurance coverage;

e. a list of any other names under which the wholesale distributor does business or was formerly known;

f. names of corporate officers and managerial employees;

g. a list of all disciplinary actions by state and federal agencies involving wholesale distribution of drugs for the last four years, if the selling wholesale distributor supplies it upon request by the purchasing wholesale distributor; and

h. a description, including the address, dimensions and other relevant information, of each facility used for prescription drug storage and distribution.

L.2005,c.206,s.17.